Collegium Pharmaceutical Inc
NASDAQ:COLL
Collegium Pharmaceutical Inc
Inventory
Collegium Pharmaceutical Inc
Inventory Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Inventory | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Collegium Pharmaceutical Inc
NASDAQ:COLL
|
Inventory
$38.1m
|
CAGR 3-Years
-16%
|
CAGR 5-Years
17%
|
CAGR 10-Years
N/A
|
|
|
Johnson & Johnson
NYSE:JNJ
|
Inventory
$14.1B
|
CAGR 3-Years
4%
|
CAGR 5-Years
9%
|
CAGR 10-Years
6%
|
|
|
Bristol-Myers Squibb Co
NYSE:BMY
|
Inventory
$2.8B
|
CAGR 3-Years
6%
|
CAGR 5-Years
6%
|
CAGR 10-Years
8%
|
|
|
Pfizer Inc
NYSE:PFE
|
Inventory
$11.5B
|
CAGR 3-Years
8%
|
CAGR 5-Years
7%
|
CAGR 10-Years
4%
|
|
|
Merck & Co Inc
NYSE:MRK
|
Inventory
$6.4B
|
CAGR 3-Years
3%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
|
Eli Lilly and Co
NYSE:LLY
|
Inventory
$12.2B
|
CAGR 3-Years
41%
|
CAGR 5-Years
25%
|
CAGR 10-Years
13%
|
|
Collegium Pharmaceutical Inc
Glance View
Collegium Pharmaceutical, Inc. operates as a pharmaceutical company. The company is headquartered in Stoughton, Massachusetts and currently employs 152 full-time employees. The company went IPO on 2015-05-07. Collegium is a diversified, specialty pharmaceutical company committed to improving the lives of people living with serious medical conditions. The firm's product portfolio includes Xtampza ER, an abuse-deterrent, extended-release, oral formulation of oxycodone; and Nucynta ER and Nucynta IR (Nucynta Products), which are extended-release (ER) and immediate-release (IR) formulations of tapentadol. Xtampza ER is formulated using its abuse-deterrent technology platform, DETERx. Xtampza ER is for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment. Nucynta ER is indicated for the management of pain severe enough to require daily, around-the-clock, long-term opioid treatment, including neuropathic pain. Nucynta IR is indicated for the management of acute pain severe enough to require an opioid analgesic.
See Also
What is Collegium Pharmaceutical Inc's Inventory?
Inventory
38.1m
USD
Based on the financial report for Sep 30, 2025, Collegium Pharmaceutical Inc's Inventory amounts to 38.1m USD.
What is Collegium Pharmaceutical Inc's Inventory growth rate?
Inventory CAGR 5Y
17%
Over the last year, the Inventory growth was 0%. The average annual Inventory growth rates for Collegium Pharmaceutical Inc have been -16% over the past three years , 17% over the past five years .
